Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/86357
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNahas, Stephanie J.-
dc.contributor.authorNaegel, Steffen-
dc.contributor.authorCohen, Joshua M.-
dc.contributor.authorNing, Xiaoping-
dc.contributor.authorJanka, Lindsay-
dc.contributor.authorRamirez Campos, Verena-
dc.contributor.authorKrasenbaum, Lynda J.-
dc.contributor.authorHolle-Lee, Dagny-
dc.contributor.authorKudrow, David-
dc.contributor.authorLampl, Christian-
dc.date.accessioned2022-07-12T09:07:16Z-
dc.date.available2022-07-12T09:07:16Z-
dc.date.issued2022-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/88310-
dc.identifier.urihttp://dx.doi.org/10.25673/86357-
dc.description.sponsorshipPublikationsfonds MLU-
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc615-
dc.titleCorrection : Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine : pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studieseng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleThe journal of headache and pain-
local.bibliographicCitation.volume23-
local.bibliographicCitation.publishernameSpringer Italia-
local.bibliographicCitation.publisherplaceMilano-
local.bibliographicCitation.doi10.1186/s10194-022-01423-x-
local.openaccesstrue-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
s10194-022-01423-x.pdf1.11 MBAdobe PDFThumbnail
View/Open